What Is the GDOC ETF? A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
The Goldman Sachs Future Health Care Equity ETF actively selects innovative healthcare companies around the world. The GDOC ETF is a thematic exchange-traded fund with an active management approach and an annual distribution, so investors should review its sector concentration risk and the healthcare outlook together.
SubscribeWhat Is the Goldman Sachs Future Health Care Equity ETF?
The GDOC ETF is an actively managed exchange-traded fund. Rather than mechanically tracking a specific index, it relies on the portfolio managers' judgment to select companies tied to healthcare innovation. It looks at both US and overseas markets and offers exposure to changes in treatment technologies and healthcare services.
It suits long-term investors who can tolerate the volatility that comes from shifts in the global healthcare industry and from the results of individual stock selection.
This is an ETF managed by Goldman Sachs using an active (actively managed) approach.
How Does the Goldman Sachs Future Health Care Equity ETF Invest?
| Item | Details |
|---|---|
| Tracked Index | Not applicable, actively managed |
| Management Style | Active stock selection |
| Rebalancing Frequency | Adjusted at the manager's discretion |
| Distribution Frequency | Once a year |
| Total Expense Ratio | 0.75% |
| Fund Manager | Goldman Sachs |
The manager builds on long-term growth themes linked to healthcare innovation, while also reviewing each company's business changes and valuation. It selects US and overseas companies, focusing on fast-changing areas such as genomic analysis, precision medicine, technology-based medical procedures, and digital healthcare.
- Company selection based on the manager's judgment rather than index tracking
- An investment scope that spans global healthcare innovation themes
Goldman Sachs Future Health Care Equity ETF Size and Costs (AUM and Expense Ratio)
Assets under management (AUM) stand at $19.9M, and the total expense ratio is 0.75% per year.
For actively managed thematic exchange-traded funds, the manager's judgment contributes heavily to results. Investors should therefore check not only fees but also the durability of the investment theme, changes in holdings, and trading conditions.
Goldman Sachs Future Health Care Equity ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeThe performance of healthcare innovation themes can vary widely depending on clinical trial results, regulatory decisions, the pace of technology adoption, and the interest rate environment. Because the GDOC ETF holds areas with high growth expectations, volatility can widen when the market turns risk-averse.
Fund flows into thematic exchange-traded funds can react sensitively to the healthcare industry outlook and to the research and development results of individual companies. When looking at fund flows for the GDOC ETF, it is worth checking whether long-term growth expectations can be distinguished from the effects of short-term news.
Goldman Sachs Future Health Care Equity ETF Pros and Cons
Its active strategy focused on innovative healthcare is a strength, but the effects of sector concentration and stock selection can lead to wider swings in performance.
💪 Key Strengths
⚠️ Points to Watch
Alternative ETFs and Related Products to the Goldman Sachs Future Health Care Equity ETF
In the comparison table, the BBH ETF offers biotech-focused exposure, while the IDNA ETF offers exposure related to genomics and immunology. The MEDI ETF and MEDX ETF show different selection approaches within healthcare and medical fields, and the JDOC ETF presents an approach centered on healthcare leaders. Because each product differs in fees, AUM size, and management style, comparisons should center on the GDOC ETF's active global innovation strategy and its investment scope.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 BBH | VanEck Biotech ETF | $246.57 | -0.7% | $505.8M | 0.35% | 0.39% | +39.0% |
 IDNA | iShares Genomics Immunology and Healthcare ETF | $40.91 | -0.3% | $322.3M | 0.47% | 0.68% | +66.8% |
 MEDI | Harbor Health Care ETF | $33.54 | -1.0% | $43.2M | 0.80% | 0.04% | +12.7% |
 MEDX | Horizon Kinetics Medical ETF | $36.53 | -1.5% | $17.4M | 0.85% | 1.12% | +15.7% |
 JDOC | JPMorgan Healthcare Leaders ETF | $63.67 | -0.7% | $9.6M | 0.65% | 0.8% | +15.8% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| LLY | Lilly(Eli) & Co | 0.25% | $1273.46 | -2.5% | $1.20T | 43.3 | 0.54% |
| JNJ | Johnson & Johnson | 0.16% | $263.81 | -1.4% | $635.1B | 40.0 | 2.02% |
| AZN | Astrazeneca plc | 0.11% | $171.49 | -0.6% | $266.0B | 25.6 | 1.95% |
| MRK | Merck & Co Inc | 0.12% | $145.27 | -1.3% | $358.4B | 116.1 | 2.34% |
| BSX | Boston Scientific Corp | 0.06% | $45.69 | -0.7% | $66.2B | 18.5 | - |
 GH | Guardant Health Inc | 0.05% | $169.08 | +3.8% | $22.7B | - | - |
Goldman Sachs Future Health Care Equity ETF Investor Checkpoints
When considering the GDOC ETF, start by asking whether the healthcare innovation theme fits your investment horizon and risk tolerance. It is important to weigh the advantages of active management together with the potential for losses from sector concentration.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| Expense Ratio | Check how costs affect returns over a long holding period | Needs comparison with its category |
| Management Style | Check the direction of the manager's judgment and changes in holdings | Active selection |
| Sector Concentration | Assess the possible impact of regulation and clinical trial results | Watch for volatility |
| Currency and Trading | Check overseas exposure and trading conditions together | Needs advance verification |
Healthcare innovation companies can be sensitive to regulatory decisions, research and development results, and the emergence of competing technologies. In addition, sector concentration and overseas exposure can deepen losses independently of overall market risk, so investors should check whether their portfolio is diversified.
The GDOC ETF can be a candidate for investors who want to approach the healthcare innovation theme over the long term. However, unlike index-tracking products, the manager's judgment has a large influence, so it is advisable to check costs, changes in holdings, and sector concentration risk, and then decide in line with your own investment principles.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of August 18, 2026.
Today's 5 AI picks, all free